Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Three different categories of hypogonadism are distinguished depending on the organs or organ systems responsible for the disturbance. These are:
- Primary hypogonadism (hypergonadotropic hypogonadism)
- Secondary hypogonadism (hypogonadotropic hypogonadism)
- Target organ resistance (androgen resistance)
The clinical picture of hypogonadism depends on whether the androgen deficiency occurs during the fetal period, before puberty or in adulthood.
Hypogonadism can be caused by a number of disorders, the most frequently observed being idiopathic hypogonadotrophic hypogonadism, hypopituitarism, Klinefelter’s syndrome or late-onset hypogonadism.
Hypogonadism is a clinical condition characterized by low serum testosterone levels occurring in association with a number of the signs and symptoms. If symptoms of testosterone deficiency are present, the doctor will investigate them using various diagnostic procedures.
In all forms of male hypogonadism, androgen therapy forms the core of the treatment. If there is a desire for fertility it may be necessary to temporarily interrupt the treatment and use other procedures instead.
- European Society for Sexual Medicine (ESSM)
The European Society for Sexual Medicine (ESSM) is a not-for-profit, multidisciplinary, academic and scientific organisation dedicated to male and female sexual function and dysfunction.
- European Men's Health Forum (EMHF)
The European Men’s Health Forum (EMHF) presents a new and major opportunity for a wide range of organisations and individuals to work together to raise the profile of men’s health at a Europe-wide level and within individual countries. EMHF has been initiated by The Men’s Health Forum, the leading advocate of men’s health in England and Wales, with the support and collaboration of partners who share its aim of tackling the poor state of male health across all the countries of Europe.
- Men's Health Forum UK (MHF)
The Men’s Health Forum, which was founded in 1994, is an independent body that works with a wide range of individuals and organisations to tackle this problem. Now well-established with an active membership, we work for the development of health services that meet men’s needs and to enable men to change their risk-taking behaviours.
- Men's Health Network
Men's Health Network (MHN) is a national non-profit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.
- European School of Oncology (ESO)
ESO was founded by Umberto Veronesi and Laudomia Del Drago in 1982, with the aim of contributing to the reduction of deaths from cancer due to late diagnosis and/or inadequate treatment. ESO’s mission is reflected in its motto "Learning to Care", which stresses the concept of studying and learning and also of caring for the patient in a global sense.
Last Updated 10-03-2015